000 01469 a2200409 4500
005 20250518000710.0
264 0 _c20200316
008 202003s 0 0 eng d
022 _a1522-9653
024 7 _a10.1016/j.joca.2018.08.022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Windt, T S
245 0 0 _aEthics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials.
_h[electronic resource]
260 _bOsteoarthritis and cartilage
_c01 2019
300 _a34-40 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aDisease Progression
650 0 4 _aEthics, Research
650 0 4 _aHumans
650 0 4 _aInformed Consent
_xethics
650 0 4 _aMusculoskeletal Diseases
_xtherapy
650 0 4 _aPatient Selection
_xethics
650 0 4 _aRandomized Controlled Trials as Topic
_xethics
650 0 4 _aRegenerative Medicine
_xethics
650 0 4 _aResearch Design
650 0 4 _aRisk Assessment
_xmethods
650 0 4 _aStem Cell Transplantation
_xethics
700 1 _aNiemansburg, S L
700 1 _aVonk, L A
700 1 _avan Delden, J M
700 1 _aRoes, K C B
700 1 _aDhert, W J A
700 1 _aSaris, D B F
700 1 _aBredenoord, A L
773 0 _tOsteoarthritis and cartilage
_gvol. 27
_gno. 1
_gp. 34-40
856 4 0 _uhttps://doi.org/10.1016/j.joca.2018.08.022
_zAvailable from publisher's website
999 _c28863597
_d28863597